| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297483A Human protease and use of such protease for pharmaceutical applications and for reducing allergenicity of non-human proteins |
| 05/30/2001 | CN1297454A Novel omega-conotoxin peptides |
| 05/30/2001 | CN1297452A Modified factor VIII |
| 05/30/2001 | CN1296976A Polypeptide-human epidermal growth factor receptor protein 25 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296972A Polypeptide-human myosin heavy chain 74 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296971A Polypeptide-huntingtin protein interactive protein 65 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296969A Polypeptide-human X chromosome linked gene expression protein 14 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296965A Polypeptide-human fibrous growth factor receptor 46 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296963A Polypeptide-human vascular epithelium cadherin 54 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296961A Polypeptide-human CDC4 analogous protein 13 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296960A Polypeptide-human CCR4 related protein 31 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296958A Polypeptide-human G protein 44 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296955A Human susceptible protein and its coding sequence |
| 05/30/2001 | CN1296954A Human membrane protein containing C2 structural domain and its coding sequence |
| 05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |
| 05/30/2001 | CN1066345C Growth hormone releasing factor analogs |
| 05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
| 05/29/2001 | US6239265 Oligonucleotides having chiral phosphorus linkages |
| 05/29/2001 | US6239259 Multivalent and multispecific antigen-binding protein |
| 05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
| 05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
| 05/29/2001 | US6238903 Purified, isolated nucleic acid |
| 05/29/2001 | US6238894 Culture product of helicobacter; catalyst |
| 05/29/2001 | US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders |
| 05/29/2001 | US6238891 Amplification of transcription and recovery of consequent protein in mammalian cells; mix suppressor solute and propagating cells in solution, recover and purify protein from cell culture |
| 05/29/2001 | US6238884 End selection in directed evolution |
| 05/29/2001 | US6238883 Neurotransmitter transporter SC6 |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238881 Nucleotide sequence which codes for p115 rho-guanine exchange factor involved in cell signalling; therapeutics; diagnostics; recombinant culture production; antibodies; probes |
| 05/29/2001 | US6238880 Enzymatic digestion of invertase of saccharomyces cerevisiae by hydrolysis in presence of exogenous proteases in acid media, then recovering hydrolysate; white wines |
| 05/29/2001 | US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells |
| 05/29/2001 | US6238861 Neurofibromatosis gene |
| 05/29/2001 | US6238859 Virus protein antigens of the JC virus |
| 05/29/2001 | US6238858 Producing secondary virus such as togavirus or retrovirus in producer host cell for subsequent infection of target cells by using chimeric primary virus or combination which direct production in the host cells; gene therapy |
| 05/29/2001 | US6238670 Compositions and methods employing a ligand for CD21 or CD19 for modulating the immune response to an antigen |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2065292C Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 05/29/2001 | CA2064915C Tumour necrosis factor binding ligands |
| 05/29/2001 | CA2043762C Lipopeptide deacylase |
| 05/29/2001 | CA2034881C Factor x-laci hybrid protein |
| 05/29/2001 | CA2031286C Methods for the biological inactivation of nucleic acids |
| 05/25/2001 | WO2001036977A2 Identification of disease markers involving mass-based-separation |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036643A1 Nucleic acid construct for optimized production of products |
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036589A2 Human ex vivo immune system |
| 05/25/2001 | WO2001036489A2 Erythropoietin forms with improved properties |
| 05/25/2001 | WO2001036486A2 Scfv antibodies against disease associated molecules |
| 05/25/2001 | WO2001036485A2 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036472A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036463A2 Genes specifically expressed in human dendritic cells |
| 05/25/2001 | WO2001036461A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036432A2 18 human secreted proteins |
| 05/25/2001 | WO2001036001A2 Interferon gamma conjugates |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | WO2001035992A1 Recombinant chlamydia vaccine |
| 05/25/2001 | WO2001035980A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 05/25/2001 | WO2001035903A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2000075278A3 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 05/25/2001 | WO2000075190A3 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | WO1999063087A8 G-protein coupled receptor, named 2871 receptor |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2391925A1 Antibodies |
| 05/25/2001 | CA2391908A1 Novel polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391906A1 Nucleic acid construct for optimized production of products |
| 05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391669A1 Mammalian genes: related reagents and methods |
| 05/25/2001 | CA2391530A1 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2391504A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | CA2391212A1 Methods and compositions for identifying disease markers |
| 05/25/2001 | CA2391080A1 Erythropoietin forms with improved properties |
| 05/25/2001 | CA2390607A1 Materials and methods for detection and treatment of breast cancer |
| 05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | CA2390292A1 Interferon gamma conjugates |
| 05/25/2001 | CA2389862A1 Human monoclonal antibody against tgf-.beta.ii receptor and medicinal use thereof |
| 05/25/2001 | CA2389851A1 Human igm antibodies to chemokine receptors |